コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 management support intervention for chronic musculoskeletal pain.
2 mitations and higher incidence of multijoint musculoskeletal pain.
3 , 49% had poor functional status and 76% had musculoskeletal pain.
4 primary care patients with improved chronic musculoskeletal pain.
5 eatures of neuropathic pain in subjects with musculoskeletal pain.
6 reases in pH and plays a significant role in musculoskeletal pain.
7 re concerned about career-ending or limiting musculoskeletal pain.
8 le of HTR2A in the genetic predisposition to musculoskeletal pain.
9 -related mortality, while increasing RDI and musculoskeletal pain.
10 nic acid were pyrexia, myalgia, and bone and musculoskeletal pain.
11 improve patient-centered outcomes in chronic musculoskeletal pain.
12 new light on treatments for osteoporosis and musculoskeletal pain.
13 ion marked by gross joint laxity and chronic musculoskeletal pain.
14 included rash, lightheadedness, fatigue, and musculoskeletal pain.
15 re concerned about career-ending or limiting musculoskeletal pain.
16 e regarding a variety of causes of childhood musculoskeletal pain.
17 headache, hyperlipidemia, transaminites, and musculoskeletal pains.
20 not available, and 12% (8-19), respectively; musculoskeletal pain 26% (19-33), 39% (23-57), and 86% (
21 were general symptoms (324 [40%] patients), musculoskeletal pain (303 [38%]), headache (278 [35%]),
22 se of side effects (neutropenia, 6 patients; musculoskeletal pain, 5 patients; thrombocytosis, 4 pati
25 ignificant relationship was observed between musculoskeletal pain and high-sensitivity C-reactive pro
27 nsmitted alphavirus that causes debilitating musculoskeletal pain and inflammation and can persist fo
29 participants' understanding of their chronic musculoskeletal pain and its management in a specialist
30 ere used to examine the associations between musculoskeletal pain and lift variables, controlling for
35 the TASQ arm included GI disorders, fatigue, musculoskeletal pains, and elevations of pancreatic and
36 on in awareness of someone outside work with musculoskeletal pain; and more than ten-fold variation i
37 (NSPS) such as abdominal pain, headache and musculoskeletal pain are widespread in the community, an
40 ased risk of at least moderately troublesome musculoskeletal pain at the shoulder (odds ratio [OR] 1.
42 rmine whether the prevalence of work-related musculoskeletal pain, cancer, and other medical conditio
45 tributes to the higher prevalence of chronic musculoskeletal pain compared with pain of cutaneous ori
47 ting HR minus posttest HR) were measured and musculoskeletal pain concerns, during and after the test
50 ile fibromyalgia syndrome (FMS) is a chronic musculoskeletal pain disorder in children and adolescent
56 COX-2 inhibitors when used for arthritis and musculoskeletal pain in patients without coronary artery
57 using the visual analog scale, categorizing musculoskeletal pain into lower back pain, lower extremi
68 oking, self-rated health, arthritis, chronic musculoskeletal pain, migraines, headaches, fatigue, and
69 The most common adverse events were cough, musculoskeletal pain, nasopharyngitis, headache, back pa
70 usly treated Lyme disease but had persistent musculoskeletal pain, neurocognitive symptoms, or dysest
71 ne [<1%]), vomiting (13 [11%] vs one [<1%]), musculoskeletal pain (none vs ten [8%]), anaemia (39 [33
73 e in 250 patients with chronic (>/=3 months) musculoskeletal pain of at least moderate intensity (Bri
74 flammation, all of which may produce chronic musculoskeletal pain, often pose challenges for current
75 There were 32 adverse events (most commonly musculoskeletal pain or discomfort and mild hypoglycemia
77 tly more severe physical symptoms, including musculoskeletal pain (P = .01), vaginal problems (P < .0
79 ms underlying the high prevalence of chronic musculoskeletal pain remain poorly understood, in part b
80 al (Stepped Care for Affective Disorders and Musculoskeletal Pain [SCAMP]) conducted at 6 community-b
84 association between joint hypermobility and musculoskeletal pains, the latter occurring in the absen
87 gray matter volume in patients with chronic musculoskeletal pain versus healthy controls, as well as
93 years is not associated with an increase in musculoskeletal pain with age, and there may be a modera
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。